De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects

Toso, Christian; Meeberg, Glenda A; Bigam, David L; Oberholzer, José; Shapiro, A M James; Gutfreund, Klaus; Ma, Mang M; Mason, Andrew L; Wong, Winnie W S; Bain, Vincent G; Kneteman, Norman M

doi:10.1097/01.tp.0000262607.95372.e0

Scientific article

English

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects

ContributorsToso, Christian; Meeberg, Glenda A; Bigam, David L; Oberholzer, José; Shapiro, A M James; Gutfreund, Klaus; Ma, Mang M; Mason, Andrew L; Wong, Winnie W S; Bain, Vincent G; Kneteman, Norman M

Published inTransplantation, vol. 83, no. 9, p. 1162-1168

Publication date2007

Abstract

We report long-term outcomes and side effects after transplantation for hepatocellular carcinoma (HCC) using de novo, sirolimus-based immunosuppression (IS).

Keywords

Adult
Aged
Carcinoma, Hepatocellular/surgery
Dose-Response Relationship, Drug
Female
Graft Rejection
Humans
Immunosuppressive Agents/administration & dosage/adverse effects/therapeutic use
Liver Neoplasms/surgery
Liver Transplantation/adverse effects
Longitudinal Studies
Male
Middle Aged
Neoplasm Recurrence, Local
Patient Selection
Pilot Projects
Sirolimus/administration & dosage/adverse effects/therapeutic use
Survival Analysis
Treatment Outcome

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de chirurgie

Research groups

Transplantation et hépatologie (905)

Citation (ISO format)

TOSO, Christian et al. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. In: Transplantation, 2007, vol. 83, n° 9, p. 1162–1168. doi: 10.1097/01.tp.0000262607.95372.e0

Article (Published version)

Identifiers

PID : unige:35301
DOI : 10.1097/01.tp.0000262607.95372.e0
PMID : 17496530

Journal ISSN0041-1337

578views

0downloads

Creation01/04/2014 12:09:00

First validation01/04/2014 12:09:00

Update time14/03/2023 21:05:15

Status update14/03/2023 21:05:14

Last indexation30/10/2024 16:42:22

Archive ouverte UNIGE

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects

We report long-term outcomes and side effects after transplantation for hepatocellular carcinoma (HCC) using de novo, sirolimus-based immunosuppression (IS).

Technical informations